Elicio Therapeutics
Develops AMP-enabled cancer immunotherapies centered on the ELI-002 mutant-KRAS program.
$2.80
Pre-market+0.10 (+3.51%)
At close$2.71(−4.75%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions53 holders · as of Mar 31, 2026 | 13.85% | 2.64M shares | |
| Insiders6 holders · as of Feb 3, 2026 | 52.77% | 10.06M shares | |
| Strategic holders1 holder · as of Jul 16, 2026 | 7.39% | 1.41M shares | |
| Otherremainder | 25.99% | 4.96M shares |
19.07M company shares as of Aug 30, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (26.28M in the company's Sep 1, 2026 report, 19.07M elsewhere); stakes use the report.
Institutions13F, as of Mar 31, 2026
53 holders · 2.64M shares · 19 new positions · 32 increased · 7 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Knoll Capital Management, LLC | 630.9K | 3.31% | 0 | May 15, 2026 |
| Vanguard Capital Management LLC | 518.6K | 2.72% | +518.6Knew | May 15, 2026 |
| Balyasny Asset Management L.P. | 244.8K | 1.28% | +106.1K | May 15, 2026 |
| Geode Capital Management, LLC | 135.2K | 0.71% | +2.6K | May 15, 2026 |
| Renaissance Technologies LLC | 121.6K | 0.64% | +93.5K | May 14, 2026 |
| Millennium Management LLC | 92.8K | 0.49% | +92.8K | May 15, 2026 |
| Marshall Wace, LLP | 74.5K | 0.39% | −42.7K | May 15, 2026 |
| Susquehanna International Group, LLP | 70.8K | 0.37% | +6.8K | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Yekaterina Chudnovsky | 48.10% | 9.66M | 13D | Mar 7, 2025 ↗ |
| Moti Investments LLC | 6.10% | 1.41M | 13G | Jul 16, 2026 ↗ |
| Knoll Capital Management, LLC | 5.20% | 630.9K | 13G | Feb 5, 2025 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.
